Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LaFleur Advancing Restart of Beacon Gold Mill and Bulk Sample for Swanson Project (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Dri Healthcare Trust
T.DHT.UN
Alternate Symbol(s):
DHTRF
Healthcare
Biotechnology
DRI Healthcare Trust is a Canada-based company engaged in global pharmaceutical royalty monetization. The Company is involved in pharmaceutical royalty monetization and provides capital to inventors, academic institutions and biopharma companies. It acquires more than 25 royalties on 20-plus drugs, including Eylea, Orserdu, Omidria, Spinraza, Stelara, Vonjo, Zejula and Zytiga. Its portfolio...
includes Empaveli/Syfovre, Eylea I, Eylea II, Ilaris, Natpara, Omidria, Oracea, Orserdu I, Orserdu II, Rydapt, Simponi, Spinraza, Stelara, Vonjo I, Vonjo II, Xenpozyme, Xolair, Zejula, Zytiga, sebetralstat, and others. Its therapeutic areas include hematology, ophthalmology, influenza, endocrinology, dermatology, oncology, neurology, immunology, lysosomal storage disorder, hereditary angioedema, and others. The Company is managed by DRI Capital Inc. Its products are marketed by pharmaceutical companies, including Regeneron, Bayer, Santen; AstraZeneca; Takeda; Galderma Laboratories; and others.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:DHT.UN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(23)
•••
HermannHaller
X
Comment by
HermannHaller
on Nov 12, 2024 1:46pm
RE:RE:Another View
The fact that it is trading below IPO price, despite the multiple upgrades to the portfolio growth outlook, suggests it's great value still. jmho (note that they did pay a significant special
...more
(12)
•••
raybay_98
X
Comment by
raybay_98
on Nov 12, 2024 11:14am
RE:Another View
"is priced well. Still risky" self explanatory! IPO was $10 USD Feb 19/21. US dollar price today $9.52. Nothing to write home in my books. jmho
(6293)
•••
retiredcf
X
Post by
retiredcf
on Nov 12, 2024 6:27am
Another View
It is a relatively small entity at market cap $741M, but priced well at 9X earnings. Units are up 5.5% this year and 25% over 52-weeks. Q3 revenue of $41.55M beat estimates of $39.9M. EBITDA was $31
...more
(1462)
•••
Red_Deer
X
Comment by
Red_Deer
on Nov 08, 2024 11:00pm
RE:RayBay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Hey RayBay__Seems That You HAVE Gone PERMANENTLY AWOL From the ChemTrade Board eh ???? !!!!! DITTO For KHERSON Also Was a LOT MORE FUN With the 2 of YOU__And We ALL MISS That Now !!!!!
(70)
•••
SONOFFERGUS
X
Comment by
SONOFFERGUS
on Nov 08, 2024 5:19pm
RE:RE:Targets Raised
Shorts picking off weak hands, IMHO. If results don't beat top and bottom (and guidance, but n/a here), short loud all day. Wait two days. Buy quietly. Weak hands get
...more
(7)
•••
sunshine7
X
Comment by
sunshine7
on Nov 08, 2024 4:40pm
RE:RE:Targets Raised
I'd say it absorbed the selling pressure quite nicely today.
(12)
•••
raybay_98
X
Comment by
raybay_98
on Nov 08, 2024 11:37am
RE:Targets Raised
Targets raised, stock price goes down? They need to try lowering their targets and see if the price goes up? JMHO
(6293)
•••
retiredcf
X
Post by
retiredcf
on Nov 08, 2024 9:47am
Targets Raised
National Bank’s Zachary Evershed raised his DRI Healthcare Trust target to $19.50 from $18.50 with an “outperform” rating, while Canaccord Genuity’s Tania Armstrong-Whitworth increased her
...more
(6293)
•••
retiredcf
X
Post by
retiredcf
on Nov 08, 2024 8:39am
RBC 2
Their upside scenario target is $21.00. GLTA November 7, 2024 Outperform TSX: DHT-U; CAD 13.25 Price Target CAD 17.00
...more
(23)
•••
HermannHaller
X
Comment by
HermannHaller
on Nov 07, 2024 7:50pm
RE:RE:CIBC
I noticed that.
(12)
•••
raybay_98
X
Comment by
raybay_98
on Nov 07, 2024 3:49pm
RE:CIBC
Market behavior appears to be saying something different. JMHO
(23)
•••
HermannHaller
X
Comment by
HermannHaller
on Nov 07, 2024 10:42am
RE:CIBC
They confirmed on the conference call that one-time admin expenses resulted in EBITDA margin below historical.
(6293)
•••
retiredcf
X
Post by
retiredcf
on Nov 07, 2024 10:12am
CIBC
Have a $19.50 target. GLTA EQUITY RESEARCH November 6, 2024 Flash Research DRI HEALTHCARE TRUST Q3/24 First Look Our Conclusion DHT reported a solid Q3, with total income 4% above consensus
...more
(6293)
•••
retiredcf
X
Post by
retiredcf
on Nov 07, 2024 7:20am
RBC
November 6, 2024 DRI Healthcare Trust Q3/24 - Revenues and cash royalty receipts ahead of estimates while adj. EBITDA missed estimates TSX: DHT
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
ReGen III: Pioneering a Cleaner Lubricants Future with Patented Re-Refining
Have you held units of a TD mutual fund through a discount broker? Learn more.